Home » Stocks » Conformis

Conformis, Inc. (CFMS)

Stock Price: $0.740 USD -0.010 (-1.27%)
Updated Aug 6, 2020 9:43 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 52.90M
Revenue (ttm) 73.26M
Net Income (ttm) -30.25M
Shares Out 71.48M
EPS (ttm) -0.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $0.740
Previous Close $0.750
Change ($) -0.010
Change (%) -1.27%
Day's Open 0.779
Day's Range 0.740 - 0.779
Day's Volume 98,706
52-Week Range 0.500 - 2.680

More Stats

Market Cap 52.90M
Enterprise Value 56.94M
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 71.48M
Float 54.41M
EPS (basic) -0.46
EPS (diluted) -0.46
FCF / Share -0.10
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.38M
Short Ratio 0.95
Short % of Float 1.25%
Beta 2.12
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.72
PB Ratio 5.81
Revenue 73.26M
Operating Income -26.61M
Net Income -30.25M
Free Cash Flow -6.72M
Net Cash -4.04M
Net Cash / Share -0.06
Gross Margin 50.15%
Operating Margin -36.33%
Profit Margin -41.30%
FCF Margin -9.18%
ROA -25.98%
ROE -151.62%
ROIC -50.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$2.33*
(214.86% upside)
Low
2.00
Current: $0.740
High
3.00
Target: 2.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue77.4389.7978.1279.9066.8948.1934.60
Revenue Growth-13.77%14.94%-2.23%19.45%38.81%39.28%-
Gross Profit36.7448.4928.8126.7121.7915.817.31
Operating Income-25.13-38.69-55.85-56.14-55.96-45.43-47.31
Net Income-28.48-43.37-53.58-57.59-57.25-45.72-47.89
Shares Outstanding64.1258.8943.3441.5221.994.244.00
Earnings Per Share-0.44-0.74-1.24-1.39-2.60-10.78-11.98
Operating Cash Flow-2.84-25.18-37.86-49.13-54.45-43.54-46.83
Capital Expenditures-2.93-4.06-5.23-7.16-4.64-2.61-4.11
Free Cash Flow-5.76-29.24-43.09-56.29-59.09-46.15-50.94
Cash & Equivalents26.8624.0945.6965.8011842.3459.77
Total Debt26.1614.7929.67-0.4810.623.11
Net Cash / Debt0.699.3016.0265.8011731.7256.66
Assets72.4062.9893.8011315971.2883.89
Liabilities56.0526.7847.2918.7618.1621.4514.93
Book Value16.3536.2046.5194.0614149.8368.96
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Conformis, Inc.
Country United States
Employees 262
CEO Mark A. Augusti

Stock Information

Ticker Symbol CFMS
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: CFMS
IPO Date July 1, 2015

Description

Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; and iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia. Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.